Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Oncol. Apr 24, 2026; 17(4): 117805
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.117805
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.117805
Breast cancer in Morocco: Synthesizing two decades of national research to inform future action
Nabil Ismaili, Department of Medical Oncology, Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health (UM6SS), Mohammed VI Foundation of Sciences and Health (FM6SS), Casablanca 82403, Morocco
Fadila Guessous, Department of Oncopathology, Biology and Environment of Cancer Laboratory, Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health (UM6SS), Mohammed VI Foundation of Sciences and Health (FM6SS) Casablanca 82403, Morocco
Sanaa El Majjaoui, Department of Radiotherapy, Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health (UM6SS), Mohammed VI Foundation of Sciences and Health (FM6SS), Casablanca 82403, Morocco
Author contributions: Ismaili N conceptualized and wrote the original draft; Guessous F and El Majjaoui S contributed to critical revision, editing, and approved the final version.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Nabil Ismaili, MD, Chief Physician, Professor, Department of Medical Oncology, Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health, Anfa City, Boulevard Mohammed Taïeb Naciri, Commune Hay Hassani, Casablanca 82403, Morocco. ismailinabil@yahoo.fr
Received: December 16, 2025
Revised: December 26, 2025
Accepted: February 6, 2026
Published online: April 24, 2026
Processing time: 126 Days and 11.6 Hours
Revised: December 26, 2025
Accepted: February 6, 2026
Published online: April 24, 2026
Processing time: 126 Days and 11.6 Hours
Core Tip
Core Tip: Research over the past twenty years has defined the unique profile of breast cancer in Morocco: A disease of younger women, often diagnosed at an advanced stage. Crucially, evidence now confirms that when patients receive timely, guideline-concordant, multimodal care, including targeted therapies, survival outcomes approach global benchmarks. The synthesis of this work highlights the critical link between standardized care and survival, while exposing persistent systemic challenges like financial toxicity and diagnostic delays. This evidence base provides a clear roadmap for national action, prioritizing early detection programs, financial risk protection, and patient navigation to improve outcomes equitably.